Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
15.3 USD | +0.79% | +1.63% | -8.95% |
05/06 | Catalyst Pharmaceuticals Insider Sold Shares Worth $276,735, According to a Recent SEC Filing | MT |
30/05 | Sector Update: Health Care Stocks Mixed Late Afternoon | MT |
Sales 2024 * | 462M 38.55B | Sales 2025 * | 543M 45.35B | Capitalization | 1.79B 150B |
---|---|---|---|---|---|
Net income 2024 * | 117M 9.77B | Net income 2025 * | 161M 13.45B | EV / Sales 2024 * | 2.87 x |
Net cash position 2024 * | 469M 39.18B | Net cash position 2025 * | 700M 58.48B | EV / Sales 2025 * | 2.01 x |
P/E ratio 2024 * |
16.1
x | P/E ratio 2025 * |
11.8
x | Employees | 167 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.79% |
Latest transcript on Catalyst Pharmaceuticals, Inc.
1 day | +0.82% | ||
1 week | +1.63% | ||
Current month | -5.35% | ||
1 month | -7.41% | ||
3 months | -7.91% | ||
6 months | -4.76% | ||
Current year | -8.95% |
Managers | Title | Age | Since |
---|---|---|---|
Patrick McEnany
FOU | Founder | 76 | 01/02/01 |
Richard Daly
CEO | Chief Executive Officer | 62 | 19/15/19 |
Michael Kalb
DFI | Director of Finance/CFO | 53 | 01/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Patrick McEnany
FOU | Founder | 76 | 01/02/01 |
Donald Denkhaus
BRD | Director/Board Member | 78 | 19/15/19 |
David Tierney
BRD | Director/Board Member | 60 | 01/02/01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.05% | 28 M€ | -4.59% | ||
0.32% | 26 M€ | -6.77% | - |
Date | Price | Change | Volume |
---|---|---|---|
22/24/22 | 15.3 | +0.79% | 1 239 049 |
20/24/20 | 15.18 | +1.40% | 1,183,866 |
18/24/18 | 14.97 | -0.20% | 852,370 |
17/24/17 | 15 | -0.40% | 1,089,076 |
14/24/14 | 15.06 | -1.76% | 830,497 |
Delayed Quote Nasdaq, June 22, 2024 at 01:17 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.95% | 1.79B | |
+2.22% | 93.53B | |
-1.32% | 38.27B | |
-13.66% | 32.84B | |
+76.30% | 27.83B | |
-13.01% | 16.08B | |
+1.07% | 14.02B | |
-12.06% | 11.47B | |
+185.28% | 9.92B | |
-53.00% | 9.42B |
- Stock Market
- Equities
- CPRX Stock